Skip to main content
Erschienen in: BMC Infectious Diseases 1/2023

Open Access 01.12.2023 | Research

Awareness of and willingness to use oral pre-exposure prophylaxis (PrEP) for HIV prevention among sexually active adults in Malawi: results from the 2020 Malawi population-based HIV impact assessment

verfasst von: Alinune Nathanael Kabaghe, Victor Singano, Danielle Payne, Alice Maida, Rose Nyirenda, Kelsey Mirkovic, Andreas Jahn, Pragna Patel, Kristin Brown, Mansoor Farahani, Felix Kayigamba, Lyson Tenthani, Francis Ogollah, Andrew Auld, Fatima Zulu, Wezi Msungama, Nellie Wadonda-Kabondo

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2023

Abstract

Background

The World Health Organization recommends Pre-Exposure Prophylaxis (PrEP) for all populations at substantial risk of HIV infection. Understanding PrEP awareness and interest is crucial for designing PrEP programs; however, data are lacking in sub-Saharan Africa. In Malawi, oral PrEP was introduced in 2018. We analyzed data from the 2020 Malawi Population-based HIV Impact Assessment (MPHIA) to assess PrEP awareness and factors associated with PrEP interest in Malawi.

Methods

MPHIA 2020 was a national cross-sectional household-based survey targeting adults aged 15 + years. Oral PrEP was first described to the survey participants as taking a daily pill to reduce the chance of getting HIV. To assess awareness, participants were asked if they had ever heard of PrEP and to assess interest, were asked if they would take PrEP to prevent HIV, regardless of previous PrEP knowledge. Only sexually active HIV-negative participants are included in this analysis. We used multivariable logistic regression to assess sociodemographic factors and behaviors associated with PrEP interest. All results were weighted.

Results

We included 13,995 HIV-negative sexually active participants; median age was 29 years old. Overall, 15.0%, 95% confidence interval (CI): 14.2–15.9% of participants were aware of PrEP. More males (adjusted odds ratio (aOR): 1.3, 95% CI: 1.2–1.5), those with secondary (aOR: 1.5, 95% CI: 1.2-2.0) or post-secondary (aOR: 3.4, 95% CI: 2.4–4.9) education and the wealthiest (aOR: 1.6, 95% CI: 1.2-2.0) were aware of PrEP than female, those without education and least wealthy participants, respectively. Overall, 73.0% (95% CI: 71.8–74.1%) of participants were willing to use PrEP. Being male (aOR: 1.2; 95% CI: 1.1–1.3) and having more than one sexual partner (aOR: 1.7 95% CI: 1.4–1.9), were associated higher willingness to use PrEP.

Conclusions

In this survey, prior PrEP knowledge and use were low while PrEP interest was high. High risk sexual behavior was associated with willingness to use PrEP. Strategies to increase PrEP awareness and universal access, may reduce HIV transmission.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AGYW
Adolescent girls and young women
aOR
Adjusted odds ratio
CDC
US Centers for Disease Control and Prevention
CI
Confidence interval
HTS
HIV testing services
MPHIA
Malawi Population-based HIV Impact Assessment
MSM
Men who have sex with men
OR
Odds ratio
PEPFAR
President’s Emergency Plan for AIDS Relief
PrEP
Pre-exposure prophylaxis
VMMC
Voluntary medical male circumcision
WHO
World Health Organization

Background

Pre-exposure prophylaxis (PrEP) reduces the risk of HIV acquisition and recommended by World Health Organization (WHO) for individuals at substantial risk of HIV acquisition [1]. PrEP is currently available as an oral pill taken once daily to prevent the risk of HIV acquisition while several alternative PrEP products are in the pipeline [2, 3]. The WHO recommends PrEP to be offered in combination with other prevention services: condom and lubricant promotion, post-exposure prophylaxis (PEP), voluntary medical male circumcision (VMMC), risk reduction education, harm reduction, and other structural interventions to reduce vulnerability to HIV infection. For women, PrEP can be empowering and within their control as it can be taken without requiring consent or negotiation with partners unlike other interventions such as condom use [4].
In Malawi, PrEP roll out started in 2018 for individuals at substantial HIV risk but there is currently limited information on the awareness and willingness to use and access the intervention in the general population [5]. Most published studies on awareness, interest and use of PrEP have been among specific high-risk or priority populations such as men who have sex with men (MSM), people who inject drugs, transgender persons, and female sex workers [6, 7]. There are several qualitative studies in priority populations in Malawi in defined geographic areas and include a small sample size of female sex workers [8], adolescent girls and young women (AGYW) [9, 10] and men who have sex with men (MSM) [11]. Findings from these studies demonstrated that most participants were unaware of PrEP but were interested to use PrEP for HIV prevention. Malawi and other countries aiming to achieve epidemic control are scaling up PrEP beyond key and priority populations. PrEP reduces HIV transmission in the general population [12, 13].
To inform PrEP programming and contribute to achieving HIV epidemic control in Malawi and similar settings, there is need to understand the current levels of awareness and willingness to use PrEP as well as factors associated with awareness and willingness to use PrEP in the general population. In this context, we analyzed data from a nationally representative survey to assess oral PrEP awareness and willingness and factors associated with awareness of and willingness to use PrEP among adults in Malawi.

Methods

Study design, setting and population

We analyzed data collected from the Malawi Population-based Impact Assessment (MPHIA) 2020–2021 [14]. The MPHIA was a cross-sectional, two-stage, cluster-randomized nationally representative household survey conducted in Malawi in adults aged 15 + years old. The primary objective of MPHIA was to estimate the subnational prevalence of viral load suppression and the progress towards the UNAIDS 95-95-95 goals among the adults aged 15+. The survey was implemented by the Malawi Ministry of Health and ICAP at Columbia University with funding from the President’s Emergency Plan for AIDS Relief (PEPFAR) and technical support from US Centers for Disease Control and Prevention (CDC) between January 2020 and April 2021.

Data Collection

Trained interviewers administered household and individual questionnaires to participants on mobile tablet devices with Census and Survey Processing System (CSPro) software. The individual interviews included questions on demographics, sexual behaviors, HIV testing and treatment history. HIV counselling and testing was conducted using Malawi’s HIV national testing algorithm and results provided to the participants on the same day. Data for PrEP elements were collected by first describing PrEP to the survey participants as “a process of taking a daily pill to reduce the chance of getting HIV”. This definition was valid for the PrEP modality available in the country at the time. To assess awareness, the participants were asked if they had ever heard of PrEP prior to the survey and asked if they had ever been offered PrEP (if they had heard of PrEP). The participants that were offered PrEP were then asked if they had taken or were still taking PrEP. Lastly, to assess interest, all the participants were asked if they would take PrEP to prevent HIV if they were offered. In addition, participants were asked to report on whether they had sex in the prior 12 months, the number of sexual partners in the past 12 months and for their last three sexual partners, whether they had used a condom. Participants were asked whether all partners in the past 12 months were a spouse/live-in partner, whether they were using any contraceptive, and whether they had accessed an HIV test in the prior 12 months.

Statistical analysis

Data from the survey was analyzed using STATA 16 (StataCorp LLC) accounting for the survey design. In this analysis, we only included data from (i) participants whose HIV test result was negative and were therefore eligible to receive PrEP and (ii) reported being sexually active in the preceding 12 months. We calculated weighted proportions of participants aware of, offered, and willing to use PrEP and estimated 95% confidence intervals (CI) using Jackknife variance estimation. We also conducted a bivariate logistic regression analysis for the association between willingness to use PrEP and demographic variables, reported number of sexual partners, and HIV testing in the prior 12 months. We fitted a multivariable logistic regression model to assess how awareness of and willingness to use PrEP were associated with a priori variables (age, sex, education level, residence, geographic location, marital status, sexual risk, and HIV testing). The a priori variables were selected given their biological and behavioral importance in relation to PrEP in previous literature.

Ethical considerations

The study protocol was reviewed and approved by the Institutional Review Boards of CDC, Columbia University, and the National Health Research Ethics Committee in Malawi. All participants aged 18 + years provided consent to participate while those 15–17 years old assented and had legal guardian approval.

Results

Demographic and clinical characteristics of the participants

A total of 12,815 households and 26,519 participants 15 + years old were interviewed; of these, 22,662 had HIV test results and 20,198 had an HIV-negative result (Fig. 1). Of the HIV-negative participants, 13,995 reported sexual activity in the prior 12 months.
The median age of the sexually active HIV-negative participants was 29 years old (IQR: 22–40 years old) (Table 1). Most participants were aged 20–24 years old (19.9%) or 25–29 years old (17.5); 14.7% of males reporting sexual activity in the prior 12 months were 50 + years, compared to 9.4% of females in the same age category. The highest level of education reported by most participants was primary school (61.6%) although the proportion of females who had no education (11.2%) was higher than males who had no education (6.4%). Conversely, more men (30.6%) had attended secondary education than women (21.0%). Most participants (73.0%) were married/cohabiting.
Table 1
Demographic characteristics of sexually active HIV-negative participants from MPHIA 2020–2021 household survey
Participant characteristic
Males: n (weighted %)
Female: n (weighted %)
Total: n (weighted % or interquartile range)
Total
6,432 (51.3)
7,563 (48.7)
13,995
Median age in years
30 (23–42)
28 (22–38)
29 (22–40)
Age categories in years
   
 15–19
826 (12.8)
887 (14.5)
1,713 (13.6)
 20–24
1,174 (18.2)
1,718 (21.7)
2,892 (19.9)
 25–29
910 (16.4)
1,413 (18.6)
2,323 (17.5)
 30–34
774 (13.7)
965 (13.6)
1,739 (13.6)
 35–39
693 (10.4)
884 (10.0)
1,577 (10.2)
 40–44
538 (7.7)
564 (7.0)
1,102 (7.4)
 45–50
446 (6.1)
432 (5.2)
878 (5.7)
 50+
1,071 (14.7)
700 (9.4)
1,771 (12.1)
Zone
   
 North
839 (13.4)
868 (12.2)
1,707 (12.8)
 Central East
1,262 (19.3)
1,315 (16.7)
2,577 (18.1)
 Central West
981 (22.1)
1,082 (22.0)
2,063 (22.0)
 Lilongwe City
294 (4.8)
421 (5.7)
715 (5.2)
 South East
1,373 (17.7)
1,875 (20.0)
3,248 (18.9)
 South West
1,356 (17.9)
1,631 (18.7)
2,987 (18.3)
 Blantyre City
327 (4.7)
371 (4.7)
698 (4.7)
Highest level of school respondent ever attended
   
 No education
429 (6.4)
845 (11.2)
1,274 (8.7)
 Primary
3,793 (58.2)
4,956 (65.2)
8,749 (61.6)
 Secondary
1,921 (30.6)
1,574 (21.0)
3,495 (25.9)
 More than secondary
284 (4.8)
184 (2.5)
468 (3.7)
Residence
   
 Urban
993 (16.6)
1,267 (15.8)
2,260 (16.2)
 Rural
5,439 (83.4)
6,296 (84.2)
11,735 (83.8)
Marital status
   
 Never married
1,615 (26.0)
824 (12.7)
2,439 (19.5)
 Married or living together
4,526 (69.7)
5,884 (76.5)
10,410 (73.0)
 Divorced or separated
273 (4.1)
777 (9.9)
1,050 (6.9)
 Widowed
15 (0.2)
73 (1.0)
88 (0.6)
Wealth quintile
   
 Lowest
1,096 (17.7)
1,399 (19.3)
2,495 (18.5)
 Second
1,346 (20.7)
1,566 (20.8)
2,912 (20.7)
 Middle
1,290 (19.6)
1,555 (19.9)
2,845 (19.8)
 Fourth
1,425 (21.8)
1,528 (19.7)
2,953(20.8)
 Highest
1,274 (20.2)
1,514 (20.2)
2,788 (20.2)

Awareness of PrEP and factors associated with PrEP awareness

Overall, 15.0% (95% CI: 14.2–15.9%) of the participants reported being aware of PrEP (Table 2). Awareness was higher in males (aOR: 1.3, 95% CI: 1.2–1.5), participants with secondary (aOR: 1.5, 95% CI: 1.2-2.0) and post-secondary education (aOR: 3.4, 95% CI: 2.4–4.9) and those from the fourth (aOR: 1.2, 95% CI: 1.0-1.5) and highest wealth quintiles (aOR: 1.6, 95% CI: 1.2-2.0) compared to females, those with no education and those from the lowest wealth quintile, respectively. There were also differences in awareness by geographic residence (zone) of the participants.
Table 2
Factors associated with oral PrEP awareness among sexually active HIV-negative participants from MPHIA 2020–2021 survey
Characteristic
Aware of oral PrEP (N = 13,995)
Weighted % (95% CI)
Unadjusted Odds Ratio (95% CI)
p-value
Adjusted Odds Ratio (95% CI)
p-value
Total
15.0 (14.2–15.9)
-
-
-
-
Gender
     
 Female
12.5 (11.6–13.4)
Ref
-
Ref
-
 Male
17.3 (16.2–18.5)
1.5 (1.3–1.6)
< 0.001
1.3 (1.2–1.5)
< 0.001*
Zone
     
 North
18.2 (15.5–21.3)
Ref
-
Ref
-
 Central East
13.1 (11.4–15.1)
0.7 (0.5–0.9)
0.005
0.8 (0.6-1.0)
0.023*
 Central West
11.1 (9.2–13.3)
0.6 (0.4–0.7)
< 0.001
0.7 (0.5–0.9)
0.002*
 Lilongwe City
19.7 (15.9–24.1)
1.1 (0.8–1.5)
0.556
0.6 (0.4–0.9)
0.008*
 South East
14.8 (13.2–16.5)
0.8 (0.6-1.0)
0.042
0.9 (0.7–1.1)
0.442
 South West
16.1 (14.5–17.9)
0.9 (0.7–1.1)
0.196
1.0 (0.8–1.2)
0.910
 Blantyre City
22.5 (18.2–27.6)
1.3 (0.9–1.8)
0.118
0.7 (0.5-1.0)
0.051
Age in years
     
 15–19
13.5 (11.6–15.5)
Ref
-
Ref
-
 20–24
15.2 (13.6–16.8)
1.2 (0.9–1.4)
0.195
1.1 (0.9–1.4)
0.306
 25–29
16.5 (14.9–18.3)
1.3 (1.0-1.6)
0.027*
1.2 (0.9–1.6)
0.135
 30–34
16.8 (14.8–19.1)
1.3 (1.0-1.6)
0.026
1.3 (1.0-1.7)
0.07
 35–39
15.3 (13.3–17.6)
1.2 (0.9–1.4)
0.185
1.2 (0.9–1.6)
0.174
 40–44
16.5 (14.2–19.1)
1.3 (1.0-1.6)
0.063
1.3 (0.8–1.8)
0.055
 45–50
12.9 (10.8–15.4)
0.9 (0.7–1.2)
0.681
1.1 (0.8–1.4)
0.699
 50+
11.6 (10.1–13.3)
0.8 (0.7–1.1)
0.131
1.0 (0.7–1.3)
0.851
Highest level of school respondent ever attended
     
 No education
10.6 (8.7–12.8)
Ref
-
Ref
-
 Primary
11.8 (11.0-12.6)
1.1 (0.9–1.4)
0.257
1.0 (0.8–1.2)
0.953
 Secondary
20.4 (18.8–22.1)
2.2 (1.7–2.8)
< 0.001
1.5 (1.2-2.0)
0.002*
 More than secondary
40.6 (35.5–45.9)
5.8 (4.2–7.9)
< 0.001
3.4 (2.4–4.9)
< 0.001*
Urban/rural area Indicator
     
 Rural
13.5 (12.7–14.3)
Ref
-
Ref
-
 Urban
22.6 (20.1–25.3)
1.9 (1.6–2.2)
< 0.001
1.3 (1.0-1.7)
0.064
Marital status
     
 Never married
18.3 (16.6–20.3)
Ref
-
Ref
-
 Married or living together
14.2 (13.3–15.1)
0.7 (0.6–0.8)
< 0.001
0.9 (0.7–1.1)
0.261
 Divorced or separated
13.8 (11.5–16.3)
0.7 (0.6–0.9)
0.006
0.9 (0.7–1.2)
0.512
 Widowed
12.0 (6.4–21.3)
0.6 (0.3–1.2)
0.158
0.8 (0.4–1.6)
0.524
Wealth quintile
     
 Lowest
10.6 (9.2–12.1)
Ref
-
Ref
-
 Second
11.5 (10.2–12.9)
1.1 (0.9–1.3)
0.316
1.0 (0.9–1.2)
0.717
 Middle
13.5 (12.1–14.9)
1.3 (1.1–1.6)
0.007
1.2 (1.0-1.4)
0.124
 Fourth
15.3 (13.9–16.9)
1.5 (1.3–1.8)
< 0.001
1.2 (1.0-1.5)
0.035
 Highest
23.7 (21.6–25.9)
2.6 (2.1–3.2)
< 0.001
1.6 (1.2-2.0)
0.001
* Statistically significant at p-value = 0.05

Willingness to use and factors associated with willingness to use PrEP

The proportion of people who were willing to use PrEP was 73.0% (95% CI: 71.8–74.1%) (Table 3). In the adjusted analysis (Table 3), being male (aOR: 1.2; 95% CI: 1.1–1.3) and having more than one sexual partner in the prior 12 months (aOR: 1.7; 95% CI: 1.4–1.9) were associated with higher willingness to use PrEP than being female and having only one sexual partner, respectively. Older participants were less willingness to take PrEP than younger particpants. Increasing age was associated with declining interest in PrEP. Willingness to use PrEP was higher among persons who reported being tested for HIV in the previous 12 months than among those who had never tested.
Table 3
Factors associated with willingness to use oral PrEP among sexually active adult MPHIA 2020 survey participants
Characteristic
Willing to use oral PrEP
Weighted % (95% CI)
Unadjusted Odds Ratio (95% CI)
P-value
Adjusted Odds Ratio (95% CI)
P-value
Total
73.0 (71.8–74.1)
-
-
-
-
Gender
     
 Female
71.2 (69.8–72.6)
Ref
-
Ref
-
 Male
74.7 (73.3–76.0)
1.2 (1.1–1.3)
< 0.001
1.2 (1.1–1.3)
0.001*
Zone
     
 North
78.7 (75.3–81.7)
Ref
-
Ref
-
 Central East
73.9 (71.5–76.1)
0.8 (0.6-1.0)
0.022
0.7 (0.6–0.9)
0.013*
 Central West
67.6 (64.9–70.2)
0.6 (0.5–0.7)
< 0.001
0.6 (0.4–0.7)
< 0.001*
 Lilongwe City
68.8 (65.6–71.8)
0.6 (0.5–0.8)
< 0.001
0.6 (0.5–0.9)
0.008*
 South East
77.0 (74.8–79.2)
0.9 (0.7–1.1)
0.394
0.9 (0.7–1.1)
0.273
 South West
71.4 (68.6–74.1)
0.7 (0.5–0.9)
0.002
0.7 (0.5–0.8)
0.001*
 Blantyre City
73.5 (69.4–77.2)
0.8 (0.6-1.0)
0.038
0.8 (0.6–1.2)
0.300
Age in years
     
 15–19
77.6 (75.2–79.9)
Ref
-
Ref
-
 20–24
74.8 (72.7–76.7)
0.9 (0.7-1.0)
0.043*
0.8 (0.7-1.0)
0.032
 25–29
75.3 (73.2–77.4)
0.9 (0.7–1.1)
0.149
0.9 (0.7–1.1)
0.192
 30–34
71.4 (69.1–73.6)
0.7 (0.6–0.8)
< 0.001
0.7 (0.6–0.9)
0.004*
 35–39
72.1 (69.7–74.3)
0.7 (0.6–0.9)
0.001*
0.8 (0.6–0.9)
0.016*
 40–44
72.6 (69.3–75.7)
0.8 (0.6–0.9)
0.012
0.8 (0.6–1.1)
0.113
 45–49
70.3 (67.1–73.4)
0.7 (0.6–0.8)
< 0.001
0.7 (0.6–0.9)
0.018*
 50+
65.3 (62.6–67.9)
0.5 (0.5–0.6)
< 0.001*
0.6 (0.5–0.7)
< 0.001*
Highest level of school attended
     
 No education
67.0 (63.6–70.1)
Ref
-
Ref
-
 Primary
73.2 (71.9–74.5)
1.3 (1.2–1.6)
< 0.001
1.1 (1.0-1.3)
0.117
 Secondary
75.0 (73.3–76.7)
1.5 (1.3–1.7)
< 0.001
1.2 (1.0-1.4)
0.074
 More than secondary
68.1 (63.3–72.6)
1.1 (0.8–1.4)
0.685
1.0 (0.7–1.3)
0.824
Residence
     
 Urban
72.0 (69.7–74.1)
Ref
-
Ref
-
 Rural
73.2 (71.8–74.4)
1.1 (0.9–1.2)
0.346
0.9 (0.7–1.2)
0.439
Marital status
     
 Never married
77.0 (74.7–79.1)
Ref
-
Ref
-
 Married or living together
71.4 (70.2–72.6)
0.7 (0.7–0.9)
< 0.001
1.0 (0.8–1.2)
0.834
 Divorced or separated
77.8 (74.8–80.5)
1.0 (0.9–1.3)
0.635
1.2 (1.0-1.6)
0.084
 Widowed
74.7 (63.1–83.6)
0.9 (0.5–1.5)
0.628
1.5 (0.8–2.8)
0.153
Wealth quintile
     
 Lowest
71.8 (69.2–74.2)
Ref-
-
Ref
-
 Second
73.8 (71.8–75.7)
1.1 (1.0-1.3)
0.113
1.0 (0.9–1.2)
0.661
 Middle
74.0 (71.8–76.1)
1.1 (1.0-1.3)
0.150
1.1 (0.9–1.3)
0.487
 Fourth
73.2 (71.1–75.1)
1.1 (0.9–1.3)
0.366
1.0 (0.9–1.2)
0.896
 Highest
72.0 (69.6–74.2)
1.0 (0.9–1.2)
0.900
0.9 (0.8–1.1)
0.483
Number of sexual partners
     
 1
71.1 (69.9–72.3)
Ref
-
Ref
-
 2 or more
82.2 (80.2–84.0)
1.9 (1.6–2.1)
< 0.001
1.7 (1.4–1.9)
< 0.001*
Previous HIV test ≤ 12 months
     
 Never tested
70.9 (68.0-73.7)
Ref
-
Ref
-
 Yes
74.7 (73.2–76.1)
1.4 (1.2–1.7)
0.001
1.3 (1.1–1.5)
0.008*
 No
72.0 (70.2–73.5)
1.2 (1.0-1.4)
0.096
1.1 (0.9–1.3)
0.179
* Statistically significant at p-value = 0.05

Discussion

In this nationally representative survey of adult participants within a low-income setting, we found that PrEP awareness was low but willingness to use PrEP to prevent HIV was high among HIV-negative sexually active respondents. There were disparities in awareness of PrEP by gender, geographic residence, level of education, urbanicity, and marital and wealth status. Additionally, we identified several factors associated with the willingness to use PrEP which may be important in informing strategies for PrEP delivery to further reduce HIV transmission.
From the analysis, although general awareness for PrEP was low (15%), there were notable disparities in PrEP awareness by level of education, urban residence, and wealth status. The low awareness of PrEP among those less educated and from poorer households and rural areas in our analysis may signify that the current HIV preventive strategies may not be adequately reaching these populations. Up to 84% of Malawians reside in the rural areas [15] and tend to be less educated and less wealthy. Previous studies have reported print media and internet websites as important sources of PrEP information [7, 16]. These sources may be inaccessible to poor and illiterate individuals. From MPHIA 2020 result [14], the prevalence of HIV was highest among those with no education and decreased with increasing level of education. To address these disparities, there may be need to design and utilize segmented social marketing strategies to disseminate HIV prevention information, accounting for measures such as level of education and access to messaging platforms to reach underserved populations [17]. The design of the strategies may be informed by both qualitative (understanding beliefs, attitudes, influences, and knowledge) and quantitative methods. The implementation of prevention strategies may require continued monitoring and evaluation to identify and address any emerging or remaining factors affecting reach and utilization.
The willingness to use PrEP was higher among participants who reported high risk behavior but lower in older than young people. Those who reported having sex with more than one partner were more willing to use PrEP. Both perceived risk and actual risk have been previously shown to increase willingness to use PrEP in previous studies [10, 1820]. This specific willingness to take PrEP by those with a perceived high risk may support the need to improve access to PrEP to all persons. A cluster randomized trial in Kenya reported no difference in PrEP uptake and HIV incidence between risk-based and universal PrEP delivery strategies in pregnant women [21]. The universal approach was reported to be less time-consuming and did not expose clients to uncomfortable discussions, hence being simpler [22]. Risk is only known by individuals themselves; using strategies that target specific populations may therefore be unfavorable to those with unremarkable ongoing risk or require further probing to assess the “risk”. For young people, consideration for PrEP delivery in schools, for those attending schools, and within other social activities, for those outside school may increase their access to PrEP.
Those who had accessed HTS in the prior 12 months were more aware of PrEP (Table 2) and may therefore have been more willing to use PrEP. Also, those who reported accessing HIV testing services (HTS) in the prior 12 months were more willing to use PrEP. The high willingness for those already utilizing and accessing HTS provides an opportunity to integrate PrEP services and increase access to PrEP which was low in the survey. A previous study in AGYW from Kenya and South Africa demonstrated an increase in demand when PrEP was integrated in primary care and reproductive health services [23].
Both awareness of and willingness to use PrEP were lower in female than male participants in the survey. PrEP awareness was however lower in younger people [1519] while interest was higher in this group. PrEP awareness has been identified as an important factor for the willingness to use PrEP by women in other studies [2426]. Several factors may be associated with a low PrEP awareness in females including the low level of education in female participants demonstrated in this study (Table 1) and discussed above. Empowering females by promoting girls’ education and school participation may improve awareness and utilization of HIV interventions. Incorporating school-based approaches to integrate HIV prevention messaging, including PrEP information and delivery for both boys and girls, may promote positive gender norms, health awareness and uptake of preventive measures [27].
It is worth acknowledging the strengths and limitations of these results. An important strength is the large sample size which included a nationally representative sample of the adult population. To our knowledge, this is the first analysis of PrEP awareness and interest in the general population in Malawi (outside of “priority populations”). One limitation may stem from social desirability bias where respondents provide a response which they perceive to be pleasing or acceptable to the interviewer or others. In this context, some participants would have indicated their willingness to take PrEP because they perceived that response as more acceptable. Another limitation is the measure of “willingness” to use PrEP which, for most participants, was measured only after they just learned about PrEP and, as such, may not reflect the uptake, adherence, and persistence of PrEP. Finally, the measure of “willingness” as an indication of intention, may not accurately reflect behavior (i.e., actual use of PrEP) which may need to account for other considerations. However, there were appreciable trends observed from the responses which may inform further research and strategies for PrEP delivery.

Conclusion

Strategies to reach sexually active population with PrEP information may increase awareness, willingness to use, and uptake of PrEP for HIV prevention. In low-income settings, prioritizing access to education and attainment may improve health literacy and access to information and interventions to contribute to disease prevention and control. Improving access of PrEP, by making it available, acceptable, and affordable, may increase uptake of PrEP among all people at risk of HIV acquisition. Integrating PrEP within routine health services (e.g., reproductive health, family planning, antenatal and postnatal care), may improve availability of PrEP among sexually active individuals.

Acknowledgements

We acknowledge participants involved in the survey and the MPHIA team involved in the survey implementation.

Declarations

The MPHIA study protocol was reviewed and approved by the Institutional Review Boards of CDC, Columbia University, and the National Health Research Ethics Committee in Malawi. All participants aged 18 + years provided consent to participate while those 15–17 years old assented and had legal guardian approval.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat World Health O. WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV Infection: module 12: adolescents and young adults. Geneva: World Health Organization; 2018 2018. Contract No.: WHO/CDS/HIV/18.13. World Health O. WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV Infection: module 12: adolescents and young adults. Geneva: World Health Organization; 2018 2018. Contract No.: WHO/CDS/HIV/18.13.
4.
Zurück zum Zitat Bailey JL, Molino ST, Vega AD, Badowski M. A review of HIV Pre-exposure Prophylaxis: the female perspective. Infect Dis Therapy. 2017;6(3):363–82.CrossRef Bailey JL, Molino ST, Vega AD, Badowski M. A review of HIV Pre-exposure Prophylaxis: the female perspective. Infect Dis Therapy. 2017;6(3):363–82.CrossRef
5.
Zurück zum Zitat Malawi National AIDS Commission. Revised National HIV and Prevention Strategy (2018–2020). Malawi National AIDS Commission. Revised National HIV and Prevention Strategy (2018–2020).
6.
Zurück zum Zitat Sun Z, Gu Q, Dai Y, Zou H, Agins B, Chen Q, et al. Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta-analysis of global data. J Int AIDS Soc. 2022;25(3):e25883.CrossRefPubMedPubMedCentral Sun Z, Gu Q, Dai Y, Zou H, Agins B, Chen Q, et al. Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta-analysis of global data. J Int AIDS Soc. 2022;25(3):e25883.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Yi S, Tuot S, Mwai GW, Ngin C, Chhim K, Pal K, et al. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21580.CrossRefPubMedPubMedCentral Yi S, Tuot S, Mwai GW, Ngin C, Chhim K, Pal K, et al. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21580.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Shea J, Bula A, Dunda W, Hosseinipour MC, Golin CE, Hoffman IF, et al. The drug will help protect my tomorrow: perceptions of integrating PrEP into HIV Prevention behaviors among female sex workers in Lilongwe, Malawi. AIDS Educ Prev. 2019;31(5):421–32.CrossRefPubMedPubMedCentral Shea J, Bula A, Dunda W, Hosseinipour MC, Golin CE, Hoffman IF, et al. The drug will help protect my tomorrow: perceptions of integrating PrEP into HIV Prevention behaviors among female sex workers in Lilongwe, Malawi. AIDS Educ Prev. 2019;31(5):421–32.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Maseko B, Hill LM, Phanga T, Bhushan N, Vansia D, Kamtsendero L, et al. Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi. PLoS ONE. 2020;15(1):e0226062.CrossRefPubMedPubMedCentral Maseko B, Hill LM, Phanga T, Bhushan N, Vansia D, Kamtsendero L, et al. Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi. PLoS ONE. 2020;15(1):e0226062.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hill LM, Maseko B, Chagomerana M, Hosseinipour MC, Bekker L-G, Pettifor A, et al. HIV risk, risk perception, and PrEP interest among adolescent girls and young women in Lilongwe, Malawi: operationalizing the PrEP cascade. J Int AIDS Soc. 2020;23(S3):e25502.CrossRefPubMedPubMedCentral Hill LM, Maseko B, Chagomerana M, Hosseinipour MC, Bekker L-G, Pettifor A, et al. HIV risk, risk perception, and PrEP interest among adolescent girls and young women in Lilongwe, Malawi: operationalizing the PrEP cascade. J Int AIDS Soc. 2020;23(S3):e25502.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Mpunga E, Persaud N, Akolo C, Boyee D, Kamanga G, Trapence G, et al. Readiness for Use of HIV Preexposure Prophylaxis among men who have sex with men in Malawi: Qualitative Focus Group and interview study. JMIR Public Health Surveill. 2021;7(10):e26177.CrossRefPubMedPubMedCentral Mpunga E, Persaud N, Akolo C, Boyee D, Kamanga G, Trapence G, et al. Readiness for Use of HIV Preexposure Prophylaxis among men who have sex with men in Malawi: Qualitative Focus Group and interview study. JMIR Public Health Surveill. 2021;7(10):e26177.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.CrossRefPubMedPubMedCentral Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.CrossRefPubMed Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.CrossRefPubMed
14.
Zurück zum Zitat Ministry of Health (MOH) M,. Malawi Population-based HIV Impact Assessment 2020–2021 (MPHIA 2020–2021): Final Report Lilongwe: MOH, Malawi. ; 2022 November 2022. Ministry of Health (MOH) M,. Malawi Population-based HIV Impact Assessment 2020–2021 (MPHIA 2020–2021): Final Report Lilongwe: MOH, Malawi. ; 2022 November 2022.
15.
Zurück zum Zitat Malawi National Statistical Office. 2018 Population and Housing Census. Government of Malawi; 2019. Malawi National Statistical Office. 2018 Population and Housing Census. Government of Malawi; 2019.
16.
Zurück zum Zitat Lim SH, Mburu G, Bourne A, Pang J, Wickersham JA, Wei CKT, et al. Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: findings from an online survey. PLoS ONE. 2017;12(9):e0182838.CrossRefPubMedPubMedCentral Lim SH, Mburu G, Bourne A, Pang J, Wickersham JA, Wei CKT, et al. Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: findings from an online survey. PLoS ONE. 2017;12(9):e0182838.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Gomez A, Loar R, Kramer AE, Garnett GP. Reaching and targeting more effectively: the application of market segmentation to improve HIV prevention programmes. J Int AIDS Soc. 2019;22(4):e25318.CrossRefPubMedPubMedCentral Gomez A, Loar R, Kramer AE, Garnett GP. Reaching and targeting more effectively: the application of market segmentation to improve HIV prevention programmes. J Int AIDS Soc. 2019;22(4):e25318.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Hill LM, Golin CE, Saidi F, Phanga T, Tseka J, Young A, et al. Understanding PrEP decision making among pregnant women in Lilongwe, Malawi: a mixed-methods study. J Int AIDS Soc. 2022;25(9):e26007.CrossRefPubMedPubMedCentral Hill LM, Golin CE, Saidi F, Phanga T, Tseka J, Young A, et al. Understanding PrEP decision making among pregnant women in Lilongwe, Malawi: a mixed-methods study. J Int AIDS Soc. 2022;25(9):e26007.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Draper BL, Fowkes FJI, Oo ZM, Thein ZW, Aung PP, Veronese V, et al. Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar. J Int AIDS Soc. 2017;20(1):21885.CrossRefPubMedPubMedCentral Draper BL, Fowkes FJI, Oo ZM, Thein ZW, Aung PP, Veronese V, et al. Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar. J Int AIDS Soc. 2017;20(1):21885.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Coulaud PJ, Sagaon-Teyssier L, M’Madi Mrenda B, Maradan G, Mora M, Bourrelly M, et al. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - expertise France). Trop Med Int Health. 2018;23(10):1084–91.CrossRefPubMed Coulaud PJ, Sagaon-Teyssier L, M’Madi Mrenda B, Maradan G, Mora M, Bourrelly M, et al. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - expertise France). Trop Med Int Health. 2018;23(10):1084–91.CrossRefPubMed
21.
Zurück zum Zitat Kinuthia J, Dettinger JC, Stern J, Ngumbau N, Ochieng B, Gómez L, et al. Risk-based versus universal PrEP delivery during pregnancy: a cluster randomized trial in Western Kenya from 2018 to 2019. J Int AIDS Soc. 2023;26(2):e26061.CrossRefPubMedPubMedCentral Kinuthia J, Dettinger JC, Stern J, Ngumbau N, Ochieng B, Gómez L, et al. Risk-based versus universal PrEP delivery during pregnancy: a cluster randomized trial in Western Kenya from 2018 to 2019. J Int AIDS Soc. 2023;26(2):e26061.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Mwongeli N, Wagner AD, Dettinger JC, Pintye J, Brown Trinidad S, Awuor M, et al. PrEP gives the woman the control: Healthcare Worker perspectives on using pre-exposure Prophylaxis (PrEP) during pregnancy and Postpartum in Kenya. J Int Association Providers AIDS Care (JIAPAC). 2022;21:23259582221111068.CrossRef Mwongeli N, Wagner AD, Dettinger JC, Pintye J, Brown Trinidad S, Awuor M, et al. PrEP gives the woman the control: Healthcare Worker perspectives on using pre-exposure Prophylaxis (PrEP) during pregnancy and Postpartum in Kenya. J Int Association Providers AIDS Care (JIAPAC). 2022;21:23259582221111068.CrossRef
23.
Zurück zum Zitat Celum CL, Bukusi EA, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, et al. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project. J Int AIDS Soc. 2022;25(7):e25962.CrossRefPubMedPubMedCentral Celum CL, Bukusi EA, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, et al. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project. J Int AIDS Soc. 2022;25(7):e25962.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Blackstock OJ, Platt J, Golub SA, Anakaraonye AR, Norton BL, Walters SM, et al. A pilot study to evaluate a novel pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at high risk for HIV Infection. AIDS Behav. 2021;25(5):1411–22.CrossRefPubMedPubMedCentral Blackstock OJ, Platt J, Golub SA, Anakaraonye AR, Norton BL, Walters SM, et al. A pilot study to evaluate a novel pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at high risk for HIV Infection. AIDS Behav. 2021;25(5):1411–22.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat O’Malley TL, Egan JE, Hawk ME, Krier SE, Burke JG. Intimate Partner Violence, HIV Pre-exposure Prophylaxis (PrEP) acceptability, and attitudes about Use: perspectives of women seeking care at a Family Planning Clinic. AIDS Behav. 2021;25(2):427–37.CrossRefPubMed O’Malley TL, Egan JE, Hawk ME, Krier SE, Burke JG. Intimate Partner Violence, HIV Pre-exposure Prophylaxis (PrEP) acceptability, and attitudes about Use: perspectives of women seeking care at a Family Planning Clinic. AIDS Behav. 2021;25(2):427–37.CrossRefPubMed
26.
Zurück zum Zitat Zhang C, McMahon J, Simmons J, Brown LL, Nash R, Liu Y, Suboptimal HIV. Pre-exposure Prophylaxis awareness and willingness to use among women who use Drugs in the United States: a systematic review and Meta-analysis. AIDS Behav. 2019;23(10):2641–53.CrossRefPubMedPubMedCentral Zhang C, McMahon J, Simmons J, Brown LL, Nash R, Liu Y, Suboptimal HIV. Pre-exposure Prophylaxis awareness and willingness to use among women who use Drugs in the United States: a systematic review and Meta-analysis. AIDS Behav. 2019;23(10):2641–53.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Godfrey-Faussett P, Frescura L, Abdool Karim Q, Clayton M, Ghys PD. HIV prevention for the next decade: appropriate, person-centred, prioritised, effective, combination prevention. PLoS Med. 2022;19(9):e1004102.CrossRefPubMedPubMedCentral Godfrey-Faussett P, Frescura L, Abdool Karim Q, Clayton M, Ghys PD. HIV prevention for the next decade: appropriate, person-centred, prioritised, effective, combination prevention. PLoS Med. 2022;19(9):e1004102.CrossRefPubMedPubMedCentral
Metadaten
Titel
Awareness of and willingness to use oral pre-exposure prophylaxis (PrEP) for HIV prevention among sexually active adults in Malawi: results from the 2020 Malawi population-based HIV impact assessment
verfasst von
Alinune Nathanael Kabaghe
Victor Singano
Danielle Payne
Alice Maida
Rose Nyirenda
Kelsey Mirkovic
Andreas Jahn
Pragna Patel
Kristin Brown
Mansoor Farahani
Felix Kayigamba
Lyson Tenthani
Francis Ogollah
Andrew Auld
Fatima Zulu
Wezi Msungama
Nellie Wadonda-Kabondo
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2023
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08683-1

Weitere Artikel der Ausgabe 1/2023

BMC Infectious Diseases 1/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.